ジャフコグループ様のオウンドメディア「& JAFCO POST」にて、弊社CEO小川のインタビュー記事が掲載されました。MOLCUREの原点から現在の私たちが見据えるビジョンまでをまとめていただいております。 L […]
Our CEO Ryu Ogawa will speak at the “KBIC Pitch Vol, 2” on Apr 19. 4月19日開催の「KBIC Pitch vol,2」に、CEO 小川が登壇します。 l […]
Our CEO Ryu Ogawa and CTO Yutaro Kyono will speak at Pharma IT & Digital Health Expo 2021 at 2:15 PM on Fr […]
An interview with our CEO Ryu Ogawa was published in AnswersNews. AnswersNewsに、CEO小川のインタビューが掲載されました。 Link to a […]
Our CSO Satoshi Tamaki will speak at the ”Startup Creative Lab seminar” on Feb 26th. 2月26日開催の「Startup Creative […]
An academic paper on “High-throughput screening of peptides using mRNA/cDNA display,” conducted jointly by res […]
Our article about laboratory automation was published in Experimental Medicine Vol.39 No.1 2021 実験医学「新型コロナで変わる […]
MOLCURE’s work on drug discovery using AI and robotics was featured in the Nikkei Business Daily. MOLCUREのAIとロ […]
Our CEO Ryu Ogawa will speak at the “KBIC Pitch Vol. 1” on Feb 3, 15:29 JST. 2月3日開催の「KBIC Pitch vol,1( 資金調達/協業 […]
MOLCURE has been selected for Microsoft for Startups, a start-up program supported by Microsoft. Microsoft for […]